about
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammationGenotype-phenotype correlation for pulmonary function in cystic fibrosis.Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts.Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease.Herpetic tracheitis and polybacterial pneumonia in an immunocompetent young man is herpes tracheitis involved in the pathogenesis of bacterial pneumonia?Annual direct medical costs of bronchiectasis treatment: Impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence.The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.Occupational vocal cord dysfunction due to exposure to wood dust and xerographic toner.The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis.Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis BronchiectasisUse of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysisShortage of Fixed-Dose Combination of Antituberculous Drugs in SpainThe significant global economic burden of bronchiectasis: a pending matterInhaled Steroids, Circulating Eosinophils, Chronic Airway Infection and Pneumonia Risk in Chronic Obstructive Pulmonary Disease: A Network AnalysisBRONCHIAL INFECTION AND temporal evolution OF bronchiectasis in patients with chronic obstructive pulmonary diseaseCOPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective StudyCurrent Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease
P50
Q28071694-11A70F0A-56C7-47F4-A2C4-19490FD0C151Q35537817-D7A68950-7D6F-46C7-8317-8C68F6BF3DA5Q36380278-D7462BF6-8635-4CA7-8EFC-140D83B08E96Q37613743-0717EF79-3408-46EF-8E52-1DB91C84C640Q40258354-E1625243-DC5C-448F-B052-4673EEC32211Q42248571-4CA37A85-8D4B-4218-AE25-0F4DE8B11189Q46049767-97638EB4-7E99-434B-B98E-E979575E68E9Q46253687-955D2F6A-F2E5-4540-B3AA-93072F6E593DQ46870243-BA2EB854-D6A5-4227-B43A-05C5FF3BB12DQ47113028-9F40A934-DF45-4018-9DF1-DF576DAC237AQ50532047-B753BEAB-373A-4BF9-BE67-7402B983A71EQ50697194-BB2BD727-DB49-4FCD-A259-CA2DA0935005Q51501039-8E14F4D5-6857-4A5B-A209-F95A9EF12F8EQ54707108-D59B13AE-9B05-4244-A05E-4067EF746F17Q64134958-B8BBD2FC-A895-412A-A3AE-0D345E2670F2Q73648997-AEC9AB2F-9D61-4211-BC9A-B60F58AB0FB9Q91060004-4A3BABB5-76FA-4317-8C77-34C3D2590906Q92021917-BC937C05-03CA-45A2-B009-BC53713C3846Q92551371-D5F4A29B-4E65-40A7-891B-D9DC406922A3Q92844536-3B00EE2F-1085-4147-8E1A-1BFBB2FC32F5Q92846038-8C0E3B9D-A48E-43FA-8105-8E90942E1D88Q96119099-462FDBEB-7EAC-4950-82A3-279C66355BE9
P50
description
researcher, ORCID id # 0000-0003-0753-1771
@en
wetenschapper
@nl
name
David de la Rosa Carrillo
@ast
David de la Rosa Carrillo
@en
David de la Rosa Carrillo
@nl
type
label
David de la Rosa Carrillo
@ast
David de la Rosa Carrillo
@en
David de la Rosa Carrillo
@nl
prefLabel
David de la Rosa Carrillo
@ast
David de la Rosa Carrillo
@en
David de la Rosa Carrillo
@nl
P106
P108
P21
P31
P3835
david-de-la-rosa-carrillo
P496
0000-0003-0753-1771